World

EU regulators start review of China''s Sinovac vaccine

The European Union's drug regulator says it has started a rolling review of China's Sinovac coronavirus vaccine to assess its effectiveness and safety, a first step toward possible approval for use in the 27-nation bloc.

migrator

Published:4th May, 2021 at 4:22 PM

The European Medicines Agency said Tuesday that its decision to start the review is based on preliminary results from laboratory studies and clinical studies.

“These studies suggest that the vaccine triggers the production of antibodies” that fight the coronavirus “and may help protect against the disease,” the agency said in a statement.

The EMA added that no application has yet been submitted for marketing authorization for the vaccine.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

EU regulators start review of China''s Sinovac vaccine

The European Union's drug regulator says it has started a rolling review of China's Sinovac coronavirus vaccine to assess its effectiveness and safety, a first step toward possible approval for use in the 27-nation bloc.

Also Read

No solution for teachers protesting for 8th day

Former AIADMK MLA Prabhakar joins TVK

Tongues wag over Edappadi, CPR meeting

Earthquake with preliminary magnitude of 6.5 rattles southern, central Mexico

Remain resilient amid AI's disruptions, V-P tells students